aod9604 dosing frequency subcutaneous injection December 4, 2024 Pharmacy Compounding Advisory Committee (PCAC) Meeting Peptide Dosage Chart: 20+ Peptides
Description
The result is a 16-amino acid peptide that stimulates lipolysis through beta-3 adrenergic receptors on fat cells, without triggering IGF-1 elevation, insulin resistance, or the growth-promoting effects that make full HGH problematic for long-term metabolic use
Adjust dose, wait 1-2 weeks to assess, then consider other changes if needed
AOD-9604 administers subcutaneously, meaning into the fat layer just beneath the skin
Progress photos in consistent lighting and posture, taken every 2-4 weeks, reveal changes that gradual daily observation misses
